The DOI matches its Crossref record.
Effect of screening by clinical breast examination on breast cancer incidence and mortality after 20 years: prospective, cluster randomised controlled trial in Mumbai
Open accessAbstract
Objective: To test the efficacy of screening by clinical breast examination in downstaging breast cancer at diagnosis and in reducing mortality from the disease, when compared with no screening. Design: Prospective, cluster randomised controlled trial. Setting: 20 geographically distinct clusters located in Mumbai, India, randomly allocated to 10 screening and 10 control clusters; total trial duration was 20 years (recruitment began in May 1998; database locked in March 2019 for analysis). Participants: 151 538 women aged 35-64 with no history of breast cancer. Interventions: Women in the screening arm (n=75 360) received four screening rounds of clinical breast examination (conducted by trained female primary health workers) and cancer awareness every two years, followed by five rounds of active surveillance every two years. Women in the control arm (n=76 178) received one round of cancer awareness followed by eight rounds of active surveillance every two years. Main outcome measures: Downstaging of breast cancer at diagnosis and reduction in mortality from breast cancer. Results: Breast cancer was detected at an earlier age in the screening group than in the control group (age 55.18 (standard deviation 9.10)v 56.50 (9.10); P=0.01), with a significant reduction in the proportion of women with stage III or IV disease (37% (n=220)v 47% (n=271), P=0.001). A non-significant 15% reduction in breast cancer mortality was observed in the screening arm versus control arm in the overall study population (age 35-64; 20.82 deaths per 100 000 person years (95% confidence interval 18.25 to 23.97)v 24.62 (21.71 to 28.04); rate ratio 0.85 (95% confidence interval 0.71 to 1.01); P=0.07). However, a post hoc subset analysis showed nearly 30% relative reduction in breast cancer mortality in women aged 50 and older (24.62 (20.62 to 29.76)v 34.68 (27.54 to 44.37); 0.71 (0.54 to 0.94); P=0.02), but no significant reduction in women younger than 50 (19.53 (17.24 to 22.29)v 21.03 (18.97 to 23.44); 0.93 (0.79 to 1.09); P=0.37). A 5% reduction in all cause mortality was seen in the screening arm versus the control arm, but it was not statistically significant (rate ratio 0.95 (95% confidence interval 0.81 to 1.10); P=0.49). Conclusions: These results indicate that clinical breast examination conducted every two years by primary health workers significantly downstaged breast cancer at diagnosis and led to a non-significant 15% reduction in breast cancer mortality overall (but a significant reduction of nearly 30%in mortality in women aged ≥50). No significant reduction in mortality was seen in women younger than 50 years. Clinical breast examination should be considered for breast cancer screening in low and middle income countries. Trial registration: Clinical Trials Registry of India CTRI/2010/091/001205; ClinicalTrials.gov NCT00632047.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
GLOBOCAN 2020 Report on Global Cancer Burden: Challenges and Opportunities for Surgical Oncologists
Deo, S. V. S., Sharma, J., & Kumar, S. (2022) · Annals of Surgical Oncology · doi:10.1245/s10434-022-12151-6 · Cited by 489
Priorities for cancer research in low- and middle-income countries: a global perspective
Pramesh, C. S., Badwe, R. A., Bhoo-Pathy, N., Booth, C. M., Chinnaswamy, G., Dare, A. J., de Andrade, V. P., Hunter, D. J., Gopal, S., Gospodarowicz, M., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-01738-x · Cited by 434
Self-citationBreast cancer in India: Present scenario and the challenges ahead
Mehrotra, R., & Yadav, K. (2022) · World Journal of Clinical Oncology · doi:10.5306/wjco.v13.i3.209 · Cited by 376
Budukh, A. M., Dikshit, R., & Chaturvedi, P. (2021) · International Journal of Cancer · doi:10.1002/ijc.33712 · Cited by 10
“L E T T E R T O TH E E D I T O R Outcome of the randomized control screening trials on oral, cervix and breast cancer from India and way forward in COVID-19 pandemic situation Dear Editor, Indian researchers have conducted the randomized control screening trials on oral, cervix and breast cancers in different location…”
BackgroundSelf-citation
Metadata
- Authors
- Mittra, I., Mishra, G. A., Dikshit, R. P., Gupta, S., Kulkarni, V. Y., Shaikh, H. K. A., Shastri, S. S., Hawaldar, R., Gupta, S., Pramesh, C. S., & Badwe, R. A.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2021-02-24
- Volume
- 372
- Pages
- n256
- ISSN
- 1756-1833 (ISSN-L)
- OpenAlex
- W3131944761
- Cited by
- 184
- References
- 0
- FWCI
- 11.25
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.